These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33628172)

  • 1. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications.
    Haque M; Kumar S; Charan J; Bhatt R; Islam S; Dutta S; Abhayanand JP; Sharma Y; Sefah I; Kurdi A; Wale J; Godman B
    Front Pharmacol; 2020; 11():582154. PubMed ID: 33628172
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications.
    Sefah IA; Ogunleye OO; Essah DO; Opanga SA; Butt N; Wamaitha A; Guantai AN; Chikowe I; Khuluza F; Kibuule D; Nambahu L; Abubakar AR; Sani IH; Saleem Z; Kalungia AC; Thi Phuong TN; Haque M; Islam S; Kumar S; Sneddon J; Wamboga J; Wale J; Miljković N; Kurdi A; Martin AP; Godman B
    Front Pharmacol; 2020; 11():588106. PubMed ID: 33628173
    [No Abstract]   [Full Text] [Related]  

  • 3. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future.
    Godman B; Haque M; Islam S; Iqbal S; Urmi UL; Kamal ZM; Shuvo SA; Rahman A; Kamal M; Haque M; Jahan I; Islam MZ; Hossain MM; Munzur-E-Murshid ; Kumar S; Charan J; Bhatt R; Dutta S; Abhayanand JP; Sharma Y; Saleem Z; Phuong TNT; Kwon HY; Kurdi A; Wale J; Sefah I
    Front Public Health; 2020; 8():585832. PubMed ID: 33381485
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes in Availability, Utilization, and Prices of Medicines and Protection Equipment for COVID-19 in an Urban Population of Northern Nigeria.
    Haque M; Abubakar AR; Ogunleye OO; Sani IH; Sefah I; Kurdi A; Islam S; Godman B
    J Res Pharm Pract; 2021; 10(1):17-22. PubMed ID: 34295848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retail pharmacy prescription medicines' availability, prices and affordability in Eswatini.
    Shambira G; Suleman F
    Afr J Prim Health Care Fam Med; 2021 Sep; 13(1):e1-e11. PubMed ID: 34636605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family physicians' responses to personal protective equipment shortages in four regions in Canada: a qualitative study.
    Mathews M; Ryan D; Hedden L; Lukewich J; Marshall EG; Asghari S; Terry AL; Buote R; Meredith L; Moritz L; Spencer S; Brown JB; Christian E; Freeman TR; Gill PS; Sibbald SL; Wong E
    BMC Prim Care; 2023 Feb; 24(1):56. PubMed ID: 36849904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies.
    Leonardi Vinci D; Polidori P; Miljković N; Batista A; Amann S; Makridaki D; Kohl S
    Eur J Hosp Pharm; 2022 Sep; 29(5):242-247. PubMed ID: 34497129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Availability, price and affordability of essential medicines for managing cardiovascular diseases and diabetes: a statewide survey in Kerala, India.
    Satheesh G; Sharma A; Puthean S; Ansil T P M; E J; Raj Mishra S; Unnikrishnan MK
    Trop Med Int Health; 2020 Dec; 25(12):1467-1479. PubMed ID: 32959441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discounting of medicines in Australian community pharmacies.
    Thai LP; Vitry AI; Moss JR
    Aust Health Rev; 2014 Nov; 38(5):517-22. PubMed ID: 25099433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variation of prescription drug prices in community pharmacies: A national cross-sectional study.
    Larkin J; Moriarty F; McGuinness S; Finucane K; Fitzgerald K; Smith SM; O'Mahony JF
    Res Social Adm Pharm; 2022 Oct; 18(10):3736-3743. PubMed ID: 35618647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prices & availability of common medicines at six sites in India using a standard methodology.
    Kotwani A; Ewen M; Dey D; Iyer S; Lakshmi PK; Patel A; Raman K; Singhal GL; Thawani V; Tripathi S; Laing R
    Indian J Med Res; 2007 May; 125(5):645-54. PubMed ID: 17642500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.
    Babar ZU; Ibrahim MI; Singh H; Bukahri NI; Creese A
    PLoS Med; 2007 Mar; 4(3):e82. PubMed ID: 17388660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Social distancing and the use of PPE by community pharmacy personnel: Does evidence support these measures?
    Hasan SS; Kow CS; Zaidi STR
    Res Social Adm Pharm; 2021 Feb; 17(2):456-459. PubMed ID: 32387229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the COVID-19 Pandemic on Medical Product Procurement, Prices, and Supply Chain in Zimbabwe: Lessons for Supply Chain Resiliency.
    Yemeke TT; Umaru FA; Ferrand RA; Ozawa S
    Glob Health Sci Pract; 2023 Oct; 11(5):. PubMed ID: 37903588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy practice in emergency response during the COVID-19 pandemic: Lessons from Australia.
    Parajuli DR; Khanal S; Wechkunanukul KH; Ghimire S; Poudel A
    Res Social Adm Pharm; 2022 Aug; 18(8):3453-3462. PubMed ID: 34810136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Availability, prices and affordability of essential medicines for treatment of diabetes and hypertension in private pharmacies in Zambia.
    Kaiser AH; Hehman L; Forsberg BC; Simangolwa WM; Sundewall J
    PLoS One; 2019; 14(12):e0226169. PubMed ID: 31834889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating access to essential medicines for treating childhood cancers: a medicines availability, price and affordability study in New Delhi, India.
    Faruqui N; Martiniuk A; Sharma A; Sharma C; Rathore B; Arora RS; Joshi R
    BMJ Glob Health; 2019; 4(2):e001379. PubMed ID: 31139456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pandemic preparedness of community pharmacies for COVID-19.
    Bahlol M; Dewey RS
    Res Social Adm Pharm; 2021 Jan; 17(1):1888-1896. PubMed ID: 32417070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Where are we now: assessing the price, availability and affordability of essential medicines in Delhi as India plans free medicine for all.
    Kotwani A
    BMC Health Serv Res; 2013 Jul; 13():285. PubMed ID: 23885985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.